Large Cap Archives - Page 85 of 437

1 minute read

Cocoa Crunch, Pricing Woes – Morgan Stanley Flags Hershey’s Bitter Aftertaste, Downgrades Stock

February 12, 1:48 PM

Hershey faces stock downgrade as Morgan Stanley analyst cites concerns over mixed Q4 earnings and bleak midterm outlook amidst cocoa inflation and weakened consumer demand. Analyst Pamela Kaufman predicts input cost inflation and gross margin contraction, leading to lowered EPS estimates for 2025, despite Hershey's proactive measures and investment plans in innovation.

HSY

2 minute read

FDA Approves Takeda’s Eohilia As First Oral Treatment For Inflammed Esophagus

By Vandana Singh

February 12, 1:17 PM

Eohilia: FDA-approved oral therapy for EoE. Takeda's innovative 2mg/10mL stick packs available by February. Histologic remission achieved in studies.

TAK

2 minute read

Novo Nordisk’s Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement

By Vandana Singh

February 12, 1:15 PM

Findings on diabetes and weight loss drugs in hip replacement. Novo Nordisk's Ozempic shows a 44% reduction in joint infections, and Wegovy proves safe, reducing complications.

NVO

1 minute read

Costly Misstep? Hewlett Packard Claims $4B Losses From Autonomy Deal: Report

By Lekha Gupta

February 12, 1:04 PM

Hewlett Packard Enterprise claims a staggering $4 billion loss on Autonomy acquisition, alleging fraud by Mike Lynch. The U.S. tech giant seeks restitution in a lawsuit against Lynch and former CFO Sushovan Hussain. Following a tumultuous legal battle, HPE aims to recover losses from its $11.1 billion purchase of Autonomy in 2011. Despite a court victory in 2022, Hewlett Packard faces uncertainty over damages as Lynch prepares to appeal.

HPE

2 minute read

Consumer Inflation Expectations Hold Steady, Credit And Stock Market Outlooks Improve: New York Fed

By Piero Cingari

February 12, 12:55 PM

NY Fed's survey shows stable inflation expectations, improved credit access and bullish outlook on US stocks, but mixed sentiment on labor market.

SPY

2 minute read

FDA Advisors Set To Discuss Abbott’s TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom

By Vandana Singh

February 12, 12:00 PM

FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.

ABT

1 minute read

Martin Marietta Makes Splash In Southeast, $2.05B Acquisition Boosts Aggregates Business

By Lekha Gupta

February 12, 10:46 AM

Martin Marietta Materials announces a strategic acquisition of 20 active operations from BWI Southeast for $2.05 billion in cash, expanding its presence in key southeastern markets such as Nashville and Miami.

CRH

3 minute read

These 4 AI-Related Stocks Outside Magnificent 7 Are Already Outperforming In 2024

By Neil Dennis

February 12, 10:35 AM

Nvidia and Meta Platforms, top AI plays and members of Magnificent 7, lead S&P 500 this year. Other AI stocks like Palo Alto, Fortinet, and Juniper also show strong growth potential.

ANET

2 minute read

Citigroup Grapples With Urgent Regulatory Changes Amid Risk Measurement Concerns

By Vandana Singh

February 12, 10:28 AM

U.S. regulators, led by the Federal Reserve, demand immediate changes to Citigroup's derivative risk assessments. CEO Jane Fraser faces hurdles in revitalizing the bank's fortunes amid regulatory challenges.

2 minute read

Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B

By Vandana Singh

February 12, 10:22 AM

Gilead Sciences will acquire CymaBay Therapeutics for $4.3 billion, advancing liver disease treatment with seladelpar. FDA priority review was granted, and there is potential for significant revenue growth.

CBAY